Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Merrimack Pharmaceuticals- Inc. (MACK)

5.4 0.13 (2.47%)

08-20 16:00

Open:

5.26

Pre. Close:

5.27

High:

5.43

Low:

5.22

Volume:

37,597

Market Cap:

72M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.431 - 5.449

5.449 - 5.467

Low:

5.166 - 5.19

5.19 - 5.212

Close:

5.361 - 5.395

5.395 - 5.427

Technical analysis  (as of: 2018-08-20 4:40:26 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 6.42     One year: 7.50

Support:

Support1: 5.16    Support2: 4.95

Resistance:

Resistance1: 5.50    Resistance2: 6.42

Pivot:

5.23

Moving Averages:

MA(5): 5.20     MA(20): 5.19

MA(100): 7.30     MA(250): 9.93

MACD:

MACD(12,26): -0.15     Signal(12,26,9): -0.23

%K %D:

%K(14,3): 56.97     %D(3): 41.82

RSI:

RSI(14): 49.69

52-Week:

High: 15.4  Low: 4.71  Change(%): -53.4

Average Vol(K):

3-Month: 21751  10-Days 6392

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MACK has closed below upper band by 11.5%. Bollinger Bands are 75.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to MACK's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-08-07T12:33:05-04:00
Merrimack Pharmaceuticals (MACK) CEO Richard Peters on Q2 2018 Results - Earnings Call Transcript

2018-08-07T06:30:00-04:00
Merrimack Reports Second Quarter 2018 Financial Results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

13.34

Shares Float (M)

5.08

% Held by Insiders

61.90

% Held by Institutions

54.40

Shares Short (K)

911

Shares Short Prior Month (K)

Stock Financials

EPS

-3.950

EPS Est. Current Year

33.490

EPS Est. Next Year

-14.050

EPS Est. Next Quarter

-1.360

Forward EPS

-3.932

Book Value (p.s.)

1.100

PEG Ratio

-0.23

Profit Margin

Operating Margin

Return on Assets (ttm)

-30.9

Return on Equity (ttm)

-53.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.378

Qtrly Earnings Growth

Operating Cash Flow (M)

-104.13

Levered Free Cash Flow (M)

-64.58

Valuation

P/E

-1.37

P/E Growth Ratio

0.02

P/BV

4.91

P/S

P/CF

-0.69

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-05-26

Ex-Dividend Date

2017-05-30

Forward Dividend

Last Split Date

2017-09-06

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.